AQP4 and myeloid sarcoma: A previous study in AQP4-ab-positive NMOSD (33) found that Japanese patients and immunosuppressant drugs were associated with a lower risk of recurrence attacks, while female sex and MS disease-modifying agents increased the likelihood of relapse.